Walvax Biotechnology Co.,Ltd.’s Net Profit Rose 56% in 2022

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (300142.SZ) reported a net profit of 938.2 million yuan in 2022, up 56% year-on-year.

Meanwhile, the company posted 5.1 billion yuan in revenue, up 46.9% year-on-year.

At the end of the reporting period, it had 15.3 billion yuan in total assets and 4.3 billion yuan in total liabilities, with a liability-to-asset ratio of 28.3%.